Latest Lead News

Patriot Battery Metals has reported a significant mineral resource upgrade at its Shaakichiuwaanaan Property, reaffirming its position as a leading lithium and caesium explorer. The company also progressed its lithium-only feasibility study and environmental assessments while maintaining a strong financial position.

Sarama Resources has secured A$2.7 million to advance exploration at its Cosmo and Mt Venn gold projects in Western Australia, while arbitration over its lost Burkina Faso permit progresses.

Amcor has completed its transformative acquisition of Berry Global, reporting a 43% jump in quarterly net sales and projecting strong earnings growth for fiscal 2026. The company’s strategic portfolio review and synergy realisation efforts underpin an optimistic outlook.

Cochlear Limited has extended its on-market share buy-back program, allowing the company to repurchase up to AUD 75 million of its fully paid ordinary shares until August 2026.

HealthCo Healthcare and Wellness REIT reported a substantial $89.3 million loss for FY25, driven by tenant payment issues and portfolio downsizing, leading to suspended distributions and a debt facility extension.

TALi Digital Limited reported a sharp reduction in losses for FY25 alongside a strategic acquisition of YCDI Education Australia, signaling a pivot towards social-emotional learning. The company also secured nearly $1 million in fresh capital to support its growth ambitions.

WAM Capital Limited outperformed key ASX indices with a 22.2% portfolio increase in FY2025, declaring a strong 15.5 cents per share dividend that yields 9.1%.

HiTech Group has reported a solid 7.1% revenue increase for FY2025, driven by strong government sector demand for ICT talent and services, alongside a 10% rise in net profit after tax.

Servcorp Limited reported a landmark FY25 with revenue up 11% to $352.1 million and net profit after tax rising 36% to $53.1 million, driven by disciplined execution and strategic global expansion.

Pro Medicus has delivered a landmark FY25 with soaring revenue and profit, driven by major contract wins and strategic cloud deployments. The company’s expanding North American footprint and AI initiatives set the stage for sustained growth.

Nyrada Inc has responded to ASX inquiries confirming the timely and compliant disclosure of positive safety data from its Phase I clinical trial of Xolatryp. The company detailed the timeline of its awareness and release of information, affirming adherence to continuous disclosure rules.

Evolution Energy Minerals Limited has announced a renounceable pro-rata entitlement offer to raise up to $1.45 million, aimed at funding early development and exploration activities in Tanzania. The offer includes free attaching options and is partially underwritten, with significant implications for shareholder dilution and company control.